<p>(A) On normal cornea, VEGF, VEGFR1 and VEGFR2 were found to be presented on corneal epithelium. (B) In no treatment group, VEGF, VEGFR1 and VEGFR2 staining were found on corneal epithelium and corneal NV with co-localization with CD31 on week 1 and week 2. (C) In early treatment group, VEGF, VEGFR1 and VEGFR2 stained only on corneal epithelium on week 1 and week 2 after bevacizumab injection. No staining of VEGF, VEGFR1 and VEGFR2 on corneal vessels was found. (D) In late treatment group, staining of VEGF, VEGFR1 and VEGFR2 was found on corneal epithelium with co-localization with CD31 at 1 and 2 weeks after bevacizumab injection. Red: CD31; Green: VEGF, VEGFR1 and VEGFR2; Blue: Hoechst33258 which stains nucleus. Scale bar: 200 μm. Three...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
PURPOSE. This study was undertaken to determine whether anti-vascular endothelial growth factor (VEG...
<p>(a) Expression and localization of VEGF165, VEGFR-1, VEGFR-2, NRP-1 and P-VEGFR-2 by immunofluore...
To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bev...
PURPOSE: To evaluate the effects and underlying mechanisms of early and late subconjunctival injecti...
Vascular endothelial growth factor (VEGF) plays a key role in vasculogenesis and the pathologic neov...
The avascular nature of the cornea is disrupted when corneal neovascularization (NV) causes the form...
The microenvironment plays an important role in several immunological processes. Vascular endothelia...
Corneal avascularity is essential for the preservation of optimal vision. However, the corneal angio...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
Topical application of vascular endothelial growth factor A (VEGFA) inhibitors including Bevacizumab...
Corneal neovascularization (NV) is a severe complication associated with inflammatory or infectious ...
Purpose To study the spatial variances in ligand expression and angiogenic effect in response to th...
PURPOSE. Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular...
Satoru Kase, Iku Kikuchi, Susumu Ishida Department of Ophthalmology, Faculty of Medicine and Gradua...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
PURPOSE. This study was undertaken to determine whether anti-vascular endothelial growth factor (VEG...
<p>(a) Expression and localization of VEGF165, VEGFR-1, VEGFR-2, NRP-1 and P-VEGFR-2 by immunofluore...
To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bev...
PURPOSE: To evaluate the effects and underlying mechanisms of early and late subconjunctival injecti...
Vascular endothelial growth factor (VEGF) plays a key role in vasculogenesis and the pathologic neov...
The avascular nature of the cornea is disrupted when corneal neovascularization (NV) causes the form...
The microenvironment plays an important role in several immunological processes. Vascular endothelia...
Corneal avascularity is essential for the preservation of optimal vision. However, the corneal angio...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
Topical application of vascular endothelial growth factor A (VEGFA) inhibitors including Bevacizumab...
Corneal neovascularization (NV) is a severe complication associated with inflammatory or infectious ...
Purpose To study the spatial variances in ligand expression and angiogenic effect in response to th...
PURPOSE. Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular...
Satoru Kase, Iku Kikuchi, Susumu Ishida Department of Ophthalmology, Faculty of Medicine and Gradua...
<p>Photos taken at 1, 2, and 4 weeks after the induction of corneal NV in no treatment group and 1, ...
PURPOSE. This study was undertaken to determine whether anti-vascular endothelial growth factor (VEG...
<p>(a) Expression and localization of VEGF165, VEGFR-1, VEGFR-2, NRP-1 and P-VEGFR-2 by immunofluore...